UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
39 hedge funds and large institutions have $4.66M invested in Unity Biotechnology in 2024 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
21% less capital invested
Capital invested by funds: $5.87M → $4.66M (-$1.22M)
36% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 11
Holders
39
Holding in Top 10
3
Calls
$81K
Puts
$1K
Top Buyers
| 1 | +$45.1K | |
| 2 | +$21.3K | |
| 3 | +$20.1K | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$2.14K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.89K |
Top Sellers
| 1 | -$57.2K | |
| 2 | -$36.8K | |
| 3 | -$33.8K | |
| 4 |
BlackRock
New York
|
-$32.3K |
| 5 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
-$29.3K |